Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda exchanges : Amex save search
Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
CANF | $1.91 -3.54% 3.67% 8.7K
|
Health Technology
|
| O: 2.45%
H: 0.87%
C: -0.43%
fda namodenoson application trial
Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
MTNB | $0.18 -4.1% 0.44% 1.4M
|
Health Technology
|
| O: 4.35%
H: 11.21%
C: -0.46%
mat2203 fda treatment biopharma trial agreement
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Published: 2024-02-13 (Crawled : 14:00) - biospace.com/
LCTX | $1.14 -0.87% 0.0% 420K
|
Health Technology
|
| O: 1.85%
H: 0.83%
C: -7.27%
fda cell treatment clearance
FDA says not to use certain hip implants from Synovo – Mass Device
Published: 2024-01-03 (Crawled : 23:00) - spacfeed.com
AQU | $10.92 0.0% 3.4K
|
n/a
|
| O: -0.09%
H: 9.11%
C: -0.09%
CPT 4 | $98.07 1.85% 0.0% 540K
|
Finance
|
| O: -0.44%
H: 1.62%
C: 0.44%
ONB J | $16.45 1.61% 1.58% 2.6M
|
Finance
|
| O: 0.24%
H: 1.75%
C: 0.6%
SIF 4 | $3.02 0.17% 0.0% 8.8K
|
Electronic Technology
|
| O: 3.47%
H: 0.41%
C: -4.16%
fda device
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
Published: 2024-01-02 (Crawled : 13:30) - globenewswire.com
DXR | $9.75 0.73% 480
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: -0.07%
fda corporation blood application advanced
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
Published: 2023-12-21 (Crawled : 12:30) - globenewswire.com
MTNB | $0.18 -4.1% 0.44% 1.4M
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: -3.82%
mat2203 fda update biopharma
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
Published: 2023-12-18 (Crawled : 13:30) - biospace.com/
CANF | $1.91 -3.54% 3.67% 8.7K
|
Health Technology
|
| O: 4.69%
H: 3.77%
C: -2.83%
fda psoriasis positive response
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
fda
CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
Published: 2023-11-15 (Crawled : 18:00) - globenewswire.com
CRMD | $5.29 0.19% 0.19% 470K
|
Health Technology
|
| O: 17.25%
H: 18.26%
C: -9.26%
defencath fda hemodialysis approval bloodstream infections
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
Published: 2023-10-26 (Crawled : 13:00) - globenewswire.com
XXII 4 | $1.655 2.16% 2.11% 230K
|
Health Technology
|
| O: 2.72%
H: 3.16%
C: 0.34%
fda group
Can-Fite Submitted to FDA a Pediatric Plan to Allow Registration of Piclidenoson for the Treatment of Adolescents with Psoriasis
Published: 2023-08-18 (Crawled : 14:00) - biospace.com/
CANF | $1.91 -3.54% 3.67% 8.7K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
fda piclidenoson psoriasis treatment
CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer
Published: 2023-07-14 (Crawled : 15:00) - biospace.com/
CVM | $1.51 -3.21% 1.99% 120K
|
Health Technology
|
| O: -0.85%
H: 12.07%
C: 10.34%
fda approval positive cancer meeting
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath - June 21, 2023
Published: 2023-06-21 (Crawled : 14:20) - biospace.com/
CRMD | $5.29 0.19% 0.19% 470K
|
Health Technology
|
| O: 2.0%
H: 5.71%
C: 3.57%
fda drug resubmission application
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
Published: 2023-06-21 (Crawled : 12:00) - globenewswire.com
CRMD | $5.29 0.19% 0.19% 470K
|
Health Technology
|
| O: 2.0%
H: 5.71%
C: 3.57%
fda drug resubmission application
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
Published: 2023-06-05 (Crawled : 12:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 33.56%
H: 36.99%
C: -5.53%
tmb-001 fda pharmaceuticals grant
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce FDA Approval of ELFABRIO® (pegunigalsidase alfa-iwxj) for the Treatment of Fabry Disease
Published: 2023-05-10 (Crawled : 10:00) - prnewswire.com
PLX | $1.18 2.61% 0.0% 230K
|
Health Services
|
| O: 3.42%
H: 2.65%
C: -2.65%
elfabrio fda rare disease approval treatment global
Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications
Published: 2023-02-27 (Crawled : 17:00) - globenewswire.com
MLSS A | $0.54 -2.0% 0.0% 130K
|
Health Technology
|
| O: 1.07%
H: 38.46%
C: 16.77%
fda clearance compuflo system milestone
Can-Fite Submits Market Registration Plan to European Medicines Agency for Piclidenoson in the Treatment of Psoriasis; FDA Submission to Follow
Published: 2023-01-10 (Crawled : 15:00) - biospace.com/
CANF | $1.91 -3.54% 3.67% 8.7K
|
Health Technology
|
| O: 3.37%
H: 1.63%
C: -2.67%
treatment fda piclidenoson market submission
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
Published: 2022-10-06 (Crawled : 14:00) - globenewswire.com
XXII 4 | $1.655 2.16% 2.11% 230K
|
Health Technology
|
| O: -0.52%
H: 7.78%
C: 0.65%
fda authorized
Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer's Disease
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
ANVS | $11.49 14.22% 0.0% 320K
|
Health Technology
|
| O: 9.5%
H: 0.61%
C: -6.49%
fda disease alzheimer's buntanetap trial authorization phase 2
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.